These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9460860)

  • 1. [Strain-specific antibodies to wild poliomyelitis viruses as an index of the circulation of these viruses in a surveyed territory].
    Seĭbil' VB; Malyshkina LP; Lavrova IK; Drozdov SG
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (6):25-30. PubMed ID: 9460860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response of children immunized with poliovaccines: an evaluation using two strains of poliovirus type 1.
    Deshpande JM; Dave KH
    Indian J Med Res; 1992 Sep; 95():216-20. PubMed ID: 1335965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunoprophylaxis of poliomyelitis in Ukraine with the use of inactivated vaccine].
    Frolov AF; Sel'nikova OP; Zadorozhnaia VI; Moiseeva AV; Demchishina IV; Bondarenko VI; Zubkova NL; Doan SI; Buraia TA
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (1):49-53. PubMed ID: 15773400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Strain-specific antibodies as an indicator of the circulation of wild poliomyelitis viruses and their role in the formation of collective immunity in the population].
    Seĭbil' VB; Malyshkina LP; Lavrova IK; Efimova VF
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (4):26-31. PubMed ID: 15481915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralising antibody response to oral poliovirus vaccine after primary immunisation with inactivated poliovirus vaccine.
    Guérin N; Bregère P; Caudrelier P; Raynaud O
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):815-6. PubMed ID: 9923532
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of an enzyme-linked immunosorbent assay based on binding inhibition for type-specific quantification of poliovirus neutralization-relevant antibodies.
    Hashido M; Horie H; Abe S; Doi Y; Hashizume S; Agboatwalla M; Isomura S; Nishio O; Hagiwara A; Inouye S
    Microbiol Immunol; 1999; 43(1):73-7. PubMed ID: 10100750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies of four different specificities for neutralization of type 1 polioviruses.
    Humphrey DD; Kew OM; Feorino PM
    Infect Immun; 1982 May; 36(2):841-3. PubMed ID: 6282759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poliovirus antibody differentiation. Methods and application for strain specific diagnosis in complications after oral vaccination.
    Kuwert E; Höher PG; Thraenhart O
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):407-12. PubMed ID: 180727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing capacity of poliovirus type 3 antibodies tested against 5 different intratypic variants of poliovirus type 3. A comparative study in children immunized with live, inactivated, or both types of poliovirus vaccines.
    Böttiger M
    Arch Gesamte Virusforsch; 1971; 35(2):251-5. PubMed ID: 4332939
    [No Abstract]   [Full Text] [Related]  

  • 10. Mapping of type 1 poliovirus neutralization epitopes.
    Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F
    Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
    Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
    J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Levels of specific antibodies against poliomyelitis virus and degree of immune protection in Umbria population].
    Stagni G; Merletti L; De Rosa F
    Boll Ist Sieroter Milan; 1979 Jul; 58(3):210-5. PubMed ID: 229884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.
    Herremans TM; Reimerink JH; Buisman AM; Kimman TG; Koopmans MP
    J Immunol; 1999 Apr; 162(8):5011-8. PubMed ID: 10202050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody titers against vaccine and contemporary wild poliovirus type 1 in children immunized with IPV+OPV and young adults immunized with OPV.
    Lukashev AN; Yarmolskaya MS; Shumilina EY; Sychev DA; Kozlovskaya LI
    Virus Res; 2016 Feb; 213():162-164. PubMed ID: 26657881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Collective poliomyelitis immunity in the adult population and its impact on eradication of this infection].
    Seĭbil' VB; Malyshkina LP; Lavrova IK; Efimova VF
    Vopr Virusol; 2007; 52(3):44-7. PubMed ID: 17601053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neutralizing antibodies in the sera of persons vaccinated with intradermal poliovirus vaccine].
    Jarzabek Z; Kańtoch M
    Przegl Epidemiol; 1984; 38(3):323-6. PubMed ID: 6098935
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effectiveness of different strategies of vaccine prophylaxis for poliomyelitis in the Ukraine].
    Moĭseieva HV; Zadorozhna VI
    Lik Sprava; 2002; (2):85-8. PubMed ID: 12073271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretory and serum immunoglobulin class-specific antibodies to poliovirus after vaccination.
    Carlsson B; Zaman S; Mellander L; Jalil F; Hanson LA
    J Infect Dis; 1985 Dec; 152(6):1238-44. PubMed ID: 2999260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.
    Dragunsky EM; Ivanov AP; Wells VR; Ivshina AV; Rezapkin GV; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
    J Infect Dis; 2004 Oct; 190(8):1404-12. PubMed ID: 15378432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.